Location: St. Augustine

201 Health Park Blvd.

Suite #105

St. Augustine, Florida 32086

Tel: (904) 310-1845

Fax: (877) 622-0626

This phase 3 study is evaluating the efficacy and safety of study TQJ230 compared to placebo in the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a).

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Heart Disease

The purpose of this phase 3 study is to evaluate the effect of finerenone compared to placebo in the reduction of cardiovascular death and total Heart Failure events, including HF hospitalization and urgent visits for HF in patients suffering from HF with an ejection fraction greater than or equal to 40%.

Location(s): St. Augustine

Condition: Heart Failure

The purpose of this phase 2 study is to evaluate the bleeding profile of abelacimab compared to rivaroxaban in patients with atrial fibrillation (AF) at moderate-to-high risk of stroke.

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Atrial Fibrillation, Heart Disease

This is a randomized, double-blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of drug IONIS-AGT-LRx compared to placebo in patients with treatment-resistant hypertension (rHTN).

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Resistant Hypertension

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease